WellTheory, a virtual care platform for individuals with autoimmune diseases, announced its first employer partnership with Maven Clinic to offer the virtual women and family health provider’s employees access to nutrition and lifestyle coaching from WellTheory.
WellTheory provides patients with two virtual visits per month and unlimited messaging with coaches specializing in autoimmune diseases.
Maven Clinic is a digital reproductive health and family platform focused on women’s health from fertility to menopause.
Through the collaboration, Maven Clinic employees will have access to one-on-one video sessions, a collaborative care team through WellTheory, and unlimited messaging for longitudinal care.
“At Maven, we strive to deliver holistic, personalized care both in our product and to the team building that product,” Kate Muzzatti, chief people officer of Maven Clinic, told MobiHealthNews in an email. “We’re looking forward to offering WellTheory as a benefit to all of our employees, ensuring no Maven has to navigate their autoimmune disease alone.”
THE LARGER TREND
Maven Clinic announced partnerships to offer their women’s health services to other companies’ employees.
Last week, Maven announced it was collaborating with BSI to offer the business improvement and standards company’s employees worldwide 24/7 access to menopause services through Maven’s Menopause and Ongoing Care program.
In August, Maven announced a partnership with Amazon to offer full-time, part-time and hourly Amazon employees in 50 countries access to virtual family-building care, including IVF, support preconception, IUF, egg freezing, surrogacy and adoption.
Last March, the company released news of its purchase of London-based Naytal to speed its expansion in the U.K. and other European markets. Naytal offered online consultations for fertility concerns, pregnancy and postpartum support, and menopause care.
In 2022, Maven garnered $90 million in Series E funding, bringing the virtual clinic’s total raise to $300 million. The company gained unicorn status with a $110 million Series D funding round in 2021.
Meanwhile, WellTheory launched its enterprise solution in October to enable employers and payers to offer autoimmune care through WellTheory.